2025
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024
Lewis N, Harker E, Cleary S, Zhu Y, Grijalva C, Chappell J, Rhoads J, Baughman A, Casey J, Blair P, Jones I, Johnson C, Halasa N, Lauring A, Martin E, Gaglani M, Ghamande S, Columbus C, Steingrub J, Duggal A, Felzer J, Prekker M, Peltan I, Brown S, Hager D, Gong M, Mohamed A, Exline M, Khan A, Ferguson S, Mosier J, Qadir N, Chang S, Ginde A, Zepeski A, Mallow C, Harris E, Johnson N, Gibbs K, Kwon J, Vaughn I, Ramesh M, Safdar B, Surie D, Dawood F, Ellington S, Self W. Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024. The Journal Of Infectious Diseases 2025, jiaf185. PMID: 40198276, DOI: 10.1093/infdis/jiaf185.Peer-Reviewed Original ResearchAcute respiratory illnessVaccine effectivenessInfluenza virusDays prior to illness onsetInfluenza-associated hospitalizationsTest-negative designSentinel Surveillance NetworkImmunocompetent patientsInfluenza BInfluenza seasonImmunocompromised patientsInfluenza casesB virusInfluenzaIllness onsetPatientsRespiratory illnessMedical CenterSARS-CoV-2VaccineSurveillance networkElevated activityHospitalDaysVirus
2010
An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness
Procaccini C, De Rosa V, Galgani M, Abanni L, Calì G, Porcellini A, Carbone F, Fontana S, Horvath TL, La Cava A, Matarese G. An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness. Immunity 2010, 33: 929-941. PMID: 21145759, PMCID: PMC3133602, DOI: 10.1016/j.immuni.2010.11.024.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsCD4 AntigensCell ProliferationCells, CulturedClonal AnergyDisease ProgressionEncephalomyelitis, Autoimmune, ExperimentalForkhead Transcription FactorsHumansInterleukin-2Interleukin-2 Receptor alpha SubunitLeptinMiceMice, Inbred C57BLSignal TransductionSirolimusT-Lymphocytes, RegulatoryTOR Serine-Threonine KinasesConceptsTreg cellsAnergic stateInterleukin-2Treg cell expansionRegulatory T cellsExogenous interleukin-2T cell responsivenessCell receptor stimulationImmune toleranceT cellsCell responsivenessReceptor stimulationMTOR activationEarly downregulationMammalian targetMTOR kinase activityRapamycin (mTOR) pathwayProliferative capabilityTransient inhibitionUnderlying mechanismElevated activityEnergy metabolismCellsResponsivenessCell expansion
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply